Tuesday, 31 August 2021
Investor Ideas #Potcasts 601, #Cannabis News and #Stocks on the Move; (TSX-V: $ENTG.V) (OTCQX: $WDDMF), (TSX: $VLNS.V) (OTCQX: $VLNCF), (TSXV: $KHRN.V) (CSE: $IKNK.U.C)
Investor Ideas #Potcasts
601, #Cannabis News and #Stocks on the Move; (TSX-V: $ENTG.V) (OTCQX: $WDDMF),
(TSX: $VLNS.V) (OTCQX: $VLNCF), (TSXV: $KHRN.V) (CSE: $IKNK.U.C)
Delta, Kelowna, BC, August 31, 2021 (Invstorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/083121-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/08311ENTG-WDDMF-VLNS-KHRN-IKNK.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as insights
from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Ikänik
Farms, Inc. (CSE:
IKNK.U) announced that it
has completed the construction and state and local licensing of its Palm
Springs dispensary, consumption lounge and home delivery.
"We are very excited to
complete our flagship dispensary and consumption lounge that will set a new
standard for cannabis experiences in the Palm Springs area, with operations
targeted to begin October 2021."
said Brian Baca, CEO of Ikänik Farms.
Conveniently located one block from
"Main Street" in the heart of Palm Springs, the licensed 1,800 square
foot dispensary offers customers an open and modern shopping experience, a
highly trained staff, and a wide assortment of California's leading brands and
Ikänik products, exclusive brand apparel and other soft goods, locally inspired
to create a consumer centric shopping experience. An online reservation system
will offer customers the convenience of shopping from their home and will
support curbside pickup and home delivery.
The consumption lounge boasts 2,200
square feet of open and airy space, cascaded with natural light from its
vaulted ceilings and a state-of-the-art ventilation and filtration system to
provide an appealing venue for dispensary customers, private parties, and
special events.
The company is excited to provide
the Palm Springs area with employment opportunities ranging from store
management to budtenders and support staff positions, with well-paying jobs
that offer upward mobility and internal promotion opportunities.
"We will see dispensary revenue
commence in Q4, with the completion of our California vertical integration
supporting margin growth moving into 2022", said Ryan Ciucki, CFO Ikänik
Farms.
Khiron
Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated medical cannabis leader with
core operations in Latin America and Europe, announced that it
has received sanitary registration in Peru for Alixen™ 30 and Alixen™ 100, two
CBD-rich products, which represent the Company's first two registered finished
medical cannabis products. As registered medical products, Alixen™ 30 and
Alixen™ 100 will be available for distribution through traditional medical
channels, including pharmacies, wholesale medical distributors, and
dispensaries, greatly expanding product availability while streamlining
distribution and prescription delivery.
Currently in Peru, the Company sells
magistral preparations, or customized compound formulations, through its
exclusive agreement with Farmacia Universal. In contrast, as shelf-ready
medical cannabis products, Alixen™ 30™ and Alixen™ 100 will be made widely
available, on a non-exclusive basis in the country. Alixen™ 30 will target indications such as
anxiety, insomnia, Parkinson's Disease, and depression, while Alixen™ 100 will
be used in the treatment of epilepsy. The Company also expects to have finished
THC products available for commercial distribution in early 2022 to address
additional pathologies, including chronic pain.
In the interim, the Company will
continue to fill high-THC magistral preparation prescriptions in partnership
with Farmacia Universal and work toward listing the Company's registered
medical cannabis products in major national pharmacy chains in Peru.
Alvaro Torres, Khiron CEO and
Director, comments, "As we look to establish ourselves as the leading B2C
medical cannabis company in Latin America, we are extremely proud to have
received our first ever registration of medical cannabis products.
Khiron-branded registered medical cannabis products from Colombia will be made
available in Peru, providing patients with broader access and quicker
prescription delivery through traditional distribution channels. Combined with
the recent launch of our first Zerenia™ clinic in Peru, we have the pieces in
place to expand in Peru and deliver on our Mission of improving patients'
quality of life through medical cannabis."
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF) and Citizen
Stash Cannabis Corp. (formerly Experion Holdings Ltd) (TSXV:
CSC)
(OTCQB:
EXPFF) announced that
they have entered into an arrangement agreement pursuant to which Valens will acquire all of the issued
and outstanding common shares of Citizen Stash by way of a court-approved plan
of arrangement under the Canada Business Corporations Act, in an all share
transaction. The transaction is valued
at approximately $54.3 million on an enterprise value basis.
Under the terms of the Arrangement
Agreement, Citizen Stash shareholders will receive 0.1620 of a Valens common
share for each Citizen Stash Common Share held. The Exchange Ratio implies a
premium per Citizen Stash Common Share of approximately 35.1% based on the
15-day volume-weighted average price of the Citizen Stash Common Shares on the
TSX-V and the Valens Shares on the TSX as of the close of markets on August 27,
2021.
The Citizen Stash Acquisition is
expected to be accretive to Valens in 2021 and 2022 before synergies, and will
provide Valens with strategic, asset-light expansion into flower and pre-rolls,
the largest segments of the Canadian cannabis market currently accounting for
over 70% of retail sales. This acquisition is anticipated to solidify Valens'
position as a top tier cannabis company by enhancing the Company's market share
and adding an innovative, premium flower brand to its portfolio. Closing of the
Citizen Stash transaction will mark the third acquisition Valens has made this
year, which will accelerate Valens' strategic initiative to create a leading
global manufacturing platform, capture market share through innovative product
launches with unique consumer experiences, and expand on its existing domestic
and international distribution network to better capitalize on the global
opportunity.
Citizen Stash is a licensed
cultivator and processor of premium craft cannabis products based in Mission,
British Columbia, and will provide Valens the opportunity to unlock additional
growth with its extensive and specialized product portfolio in the premium flower
and pre-roll segments. Citizen Stash operates a unique, asset-light platform
comprised of a network of craft contract growing partners from which it
selectively sources premium bulk flower grown from Citizen Stash's industry
leading proprietary genetics. Citizen Stash manufactures and packages flower
and pre-roll products primarily through manual processes.
Citizen Stash is one of the top
performing premium brands in the flower and pre-roll categories. Based on
Hifyre data for the flower category during March to May 2021 in the markets of
Ontario, Alberta and British Columbia, Citizen Stash is the highest ranked
premium brand by market share in the flower category with an average selling
price above $13.00 per gram and is the only brand in the top 20 by market share
with an average selling price above $13.00 per gram. Within the pre-roll
category during March to May 2021 in the markets of Ontario, Alberta and
British Columbia, Citizen Stash is the third highest ranked premium brand with
average selling price above $13.00 per gram and one of only five within the top
20 overall brands. The Citizen Stash brand has demonstrated very impressive
strength in the competitive flower and pre-roll categories with year-over-year
market share gains unlike many other competitor brands – a testament to the
product quality and consumer loyalty borne out of Citizen Stash's industry
leading genetics.
Tyler Robson, Chief Executive
Officer and Chair of the Board of The Valens Company, said, "We are
excited to join forces with Citizen Stash's experienced team and broaden our
offerings in the flower and pre-roll verticals with a best-in-class brand. The
premium price tier of the flower and pre-roll segments represents the best
expansion opportunity for Valens in the flower category, as premium brands are
the hardest to build, while also capturing the highest margins. Citizen Stash's
asset light model, and proprietary genetics will provide us significant
operational flexibility and an opportunity to leverage the growing capabilities
of our existing LP partners. In short,
this strategic acquisition will allow Valens to significantly expand its
presence in the recreational market and capture a share of the largest
categories of the Canadian cannabis space without the burden of a high-cost
growing infrastructure. We are opportunistically expanding our product offering
to align with consumer demand for high quality craft cannabis flower and
pre-rolls."
Entourage Health
Corp. (formerly
WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF), a
Canadian producer and distributor of award-winning cannabis products and
brands, announced
today that its subsidiary and licence holder WeedMD RX Inc.
has signed agreements with BBCCC, Inc., a subsidiary of the The Boston Beer Company, Inc. (NYSE:
SAM)
(‘BBC’), and Ontario-based Peak Processing Solutions (‘Peak’), a subsidiary of Althea Group Holdings Ltd (ASX:AGH), to
launch a new portfolio of non-alcoholic cannabis-infused beverages in Canada,
with production commencing in Q4, 2021.
Under
the terms of the five-year development, supply, manufacturing, sales and
marketing agreements, BBC and Peak will develop the beverages with Entourage’s
cannabinoid-rich input biomass processed at Peak’s Windsor, Ontario facility.
Entourage will be the exclusive distributor of the cannabis-infused beverages
in Canada leveraging Entourage’s expansive local sales and marketing network.
“The
cannabis market is constantly evolving and with a growing base of consumers
seeking consumption alternatives, we’re excited to partner with Boston Beer and
Peak to elevate our offerings with Canadian-made, cannabis-infused beverages
developed by one of North America’s most iconic craft beer brands,” said George
Scorsis, Interim CEO and Executive Chair of Entourage. “We are proud to expand
into another consumer vertical with award-winning partners of well-known
products that will focus on all segments including the emerging self-care
market. Our collective industry expertise coupled with extensive cannabis
research and advanced branding strategies will lay the foundation for new
product collaborations and further market expansion opportunities at scale. Our
strong industry presence, sales force and reputation for consistently
delivering award-winning brands in Canada makes this an ideal collaboration.”
Peak
Founder and President, Gregg Battersby added: “The team at Peak are delighted
to partner with two industry leaders in Entourage Health and The Boston Beer
Company to develop what promises to be an exciting range of cannabis-infused
beverages. This collaboration is further validation of Peak’s significant and
unique capabilities in the Cannabis 2.0 space, and the latest in a growing list
of strategic and innovative partnerships.”
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts
visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
Potcasts is now a certified word mark
Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock
news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast , Cleantech and Climate
Change , Exploring Mining , Betting on Gaming Stocks
Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile
App
for iPhone and Android
Join our
Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665
0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Friday, 27 August 2021
Investor Ideas #Potcasts 600: #Cannabis News and #Stocks on the Move; (CSE: $BRAX.C) (OTC: $BRAXF) (OTC: $ERBB) (OTCQX: $AVCNF) (NASDAQ: $GNLN)
Investor Ideas #Potcasts
600: #Cannabis News and #Stocks on the Move; (CSE: $BRAX.C) (OTC: $BRAXF) (OTC:
$ERBB) (OTCQX: $AVCNF) (NASDAQ: $GNLN)
Delta, Kelowna, BC, August 27, 2021 (Invstoride, s.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/082721-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/08271BRAX-ERBB-AVCNF-GNLN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Greenlane Holdings, Inc. (NASDAQ: GNLN), a global house of brands and
one of the largest sellers of premium cannabis accessories, child-resistant
packaging, and specialty vaporization products, announced that its stockholders have approved
the proposed merger with KushCo
Holdings, Inc., a premier provider of ancillary products and services to
the legal cannabis and CBD industries.
Over 99%
of the votes cast on the merger proposal were voted in favor of the
Transaction. Furthermore, each other proposal submitted to stockholders at
Greenlane’s annual meeting of stockholders was approved by the requisite vote.
The Company expects to file with the Securities and Exchange Commission a Form
8-K disclosing the final voting results.
Pursuant
to the terms of the merger agreement, KushCo will become a wholly owned
subsidiary of Greenlane in an all-stock, tax-free business combination. Under
the terms of the merger agreement, KushCo’s stockholders will receive shares of
Greenlane Class A common stock based on the final exchange ratio to be
determined as of the closing date in accordance with the terms of the merger
agreement.
Avicanna Inc. (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced that, through its majority-owned
Colombian subsidiary Santa Marta Golden Hemp S.A.S. (“SMGH”), it has completed
its first commercial export of 20 kg of high CBD full spectrum psychoactive
cannabis extracts (the “Cannabis Extracts”) to Brazil in connection with the
previously announced three (3) year master supply agreement that SMGH executed
with a leading Brazilian pharmaceutical in July, 2021.
This marks the 11th country to which
Avicanna has successfully completed export of Aureus-branded products in what
stands as a demonstration of the Company’s capabilities, innovation, and
regulatory expertise. This export also validates the emergence of the global
cannabinoid sector with reliance on quality, traceability and sustainability
that Avicanna’s Aureus products offer.
With a forecasted total market size
of approximately USD $9 billion by 2021, Brazil is expected to be one of the
biggest cannabis markets globally and the largest in Latin America,
particularly for medicinal cannabis products. The Cannabis Extracts will be
used in the production of several products which will be registered and
commercialized in Brazil through RDC 327/19 that regulates manufacturing,
registration, importation and dispensing of cannabis-derived products.
Lucas Nosiglia, President of
Avicanna LATAM, commented: “This export represents a key milestone for our team
and a validation of our capabilities as we continue to lead the way with our
products and have now entered our 11th country with the Aureus brand. The
export to Brazil also confirms the regulatory pathway and acts as a proof of
concept in the largest market in South America where we aim to establish
long-lasting supply relationships with our Brazilian pharmaceutical partners.”
American
Green
(OTC: ERBB) announced that it will be expanding its
E-commerce presence by launching on Groupon.com. American Green’s premium CBD and Hemp
products will be able to be purchased with vouchers located on the Groupon.com
platform beginning next month (September 2021).
The company is excited to add sales from Groupon as another revenue
stream and hopes to echo or exceed the success it is currently enjoying
following its launch on Amazon.com.
David G. Gwyther, American
Green’s president, said, “We are
extremely excited to offer our CBD products on Groupon.com There are very few e-commerce outlets that
sell CBD direct to consumers, and Groupon is by far the largest and most
successful platform. Groupon has over 24
million customers nationwide. Consumers
throughout the country will now have direct access to all of our CBD and Hemp
products on Groupon.com.”
“American Green is always looking
for innovative ways to introduce its CBD and Hemp products to new prospects and
new marketplaces. Groupon is perfectly aligned with our goals with respect to
pioneering new ideas that drive rapid growth in e-commerce environments,” said
Kevin Davis, VP President of Sales for American Green.
The American Green offers will be
optimized and marketed under Groupon's proprietary methods which include but
are not limited to: flash sale offers, remarketing campaigns, utilization of
additional channels (such as the Groupon app and partner websites) and other
online advertising channels.
Braxia
Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company with
clinics providing innovative ketamine treatments for persons with depression
and related disorders, announced that Braxia Scientific's clinical
research and development team will commence a randomized clinical trial (RCT)
using psilocybin.
"This will be the broadest
study of its kind," said Dr. Joshua Rosenblat, the trial's principal
investigator and medical director of the Canadian Rapid Treatment Centre of
Excellence Inc. (CRTCE), a wholly owned subsidiary of Braxia Scientific.
"Whereas most other
treatment-resistant depression (TRD) studies limit participation to patients
that have not found relief from a maximum of five other potential remedies, our
research will not have an upper limit, and will even include patients that have
endured dozens of unsuccessful medical trials, including ketamine and
electroconvulsive therapy.
"By including everyone with
more than two failed medical trials, we are increasing the degree to which the
results can be applied to a larger population, making our findings much
stronger. Furthermore, we will have less exclusion criteria and are even
including patients with bipolar depression – a huge first for the field – or
comorbid disorders, which were excluded in psilocybin studies done by other
companies."
Braxia Scientific CEO Dr. Roger
McIntyre added, "Integrating psilocybin provides immense opportunity for
benefit for those dealing with treatment-resistant depression. Unfortunately,
over one-third of the more than 300 million people suffering with depression
worldwide fail to adequately respond to currently approved treatments, and thus
the TRD market is very large and disproportionately dominates the majority of
mental health services."
The study will demonstrate that the
Company can effectively conduct a randomized controlled trial using
psychedelic-assisted therapy. This will enable the Company to build the
infrastructure for future studies and future clinical care, while also
compiling efficacy data and providing the opportunity to evaluate the therapist
training program launched at the end of June 2021.
This program run by the Braxia
Institute, the Company's training centre focused on advancing psychiatric
clinical practice and health services of ketamine and psychedelic treatment
therapy, has already cultivated a multi-disciplinary group of 20 therapists
from diverse psychiatry and psychotherapy backgrounds to implement safe and
effective psilocybin-assisted therapy for patients with depression.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the Investorideas.com website and that this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now
a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto
Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
, Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T...